Translational Challenges in Drug Therapy and Delivery Systems for Treating Chronic Lower Extremity Wounds

Area of Science:

• Wound healing research
• Translational medicine
• Drug delivery systems

Background:

• Limited success in developing market-approved drugs for chronic lower extremity wounds despite extensive preclinical research.
• Current treatments heavily rely on animal models that may not accurately reflect the human chronic wound microenvironment.
• A significant translational gap exists between preclinical findings and effective human therapies for chronic wounds.

Purpose of the Study:

• To review novel drug technologies and delivery systems targeting the chronic wound microenvironment.
• To highlight preclinical models used for testing treatments in diabetic, venous, ischemic, and burn lower extremity wounds.
• To discuss key differences between preclinical models and human chronic wounds impacting drug treatment translation.

Main Methods:

• Literature review of recent advancements in wound treatment technologies.
• Analysis of preclinical models for various chronic lower extremity wound types.
• Comparative discussion of animal models versus human chronic wound characteristics.

Main Results:

• Identification of emerging drug technologies and delivery systems for chronic wound management.
• Evaluation of the suitability of current preclinical models for specific human wound types.
• Detailed comparison of microenvironmental factors in preclinical models versus human chronic wounds.

Conclusions:

• Addressing the discrepancies between preclinical models and human chronic wounds is crucial for successful drug development.
• Further refinement of preclinical models is needed to improve the translation of therapeutic strategies.
• Novel drug delivery systems show promise but require validation in human-relevant contexts.